{"id":"F2021L00358","name":"Statement of Principles concerning malignant neoplasm of the kidney (Reasonable Hypothesis) (No. 41 of 2021)","slug":"statement-of-principles-concerning-malignant-neoplasm-of-the-kidney-reasonable-hypothesis-no-41-of-2","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"in_force","isInForce":true,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":101570,"registerId":"commonwealth-F2021L00358-current","compilationNumber":null,"startDate":"2026-04-02","status":"InForce","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Statement of Principles concerning malignant neoplasm of the kidney (Reasonable Hypothesis) (No. 41 of 2021)","content":"![Commonwealth Coat of Arms](image.001.png)\n\nStatement of Principles concerning malignant neoplasm of the kidney (Reasonable Hypothesis) (No. 41 of 2021)\n\nmade under subsection 196B(2) of the\n\nVeterans' Entitlements Act 1986\n\nCompilation No. 1\n\nCompilation date: 19 September 2022\n\nIncludes amendments up to: Veterans' Entitlements (Statements of Principles—definition of \"one pack-year\") Amendment Determination 2022 (No. 94 of 2022) (F2022L01128)\n\nThe day of commencement of this Amendment Determination is 19 September 2022.\n\nAbout this compilation\n\nThis compilation\n\nThis is a compilation of the Statement of Principles concerning malignant neoplasm of the kidney (Reasonable Hypothesis) (No. 41 of 2021) that shows the text of the law as amended and in force on 19 September 2022.\n\nThe notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.\n\nUncommenced amendments\n\nThe effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Legislation Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the series page on the Legislation Register for the compiled law.\n\nApplication, saving and transitional provisions for provisions and amendments\n\nIf the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.\n\nModifications\n\nIf the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the series page on the Legislation Register for the compiled law.\n\nSelf‑repealing provisions\n\nIf a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.\n\nContents\n\n1 Name\n\n3 Authority\n\n5 Application\n\n6 Definitions\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n8 Basis for determining the factors\n\n9 Factors that must exist\n\n10 Relationship to service............................................\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nSchedule 1 - Dictionary\n\n1 Definitions\n\nEndnotes\n\nEndnote 1—About the endnotes\n\nEndnote 2—Abbreviation key\n\nEndnote 3—Legislation history\n\nEndnote 4—Amendment history\n\n  \n\n1 Name\n\nThis is the Statement of Principles concerning malignant neoplasm of the kidney (Reasonable Hypothesis) (No. 41 of 2021).\n\n3 Authority\n\nThis instrument is made under subsection 196B(2) of the Veterans' Entitlements Act 1986.\n\n5 Application\n\nThis instrument applies to a claim to which section 120A of the VEA or section 338 of the Military Rehabilitation and Compensation Act 2004 applies.\n\n6 Definitions\n\nThe terms defined in the Schedule 1 - Dictionary have the meaning given when used in this instrument.\n\n7 Kind of injury, disease or death to which this Statement of Principles relates\n\n(1) This Statement of Principles is about malignant neoplasm of the kidney and death from malignant neoplasm of the kidney.\n\nMeaning of malignant neoplasm of the kidney\n\n(2) For the purposes of this Statement of Principles, malignant neoplasm of the kidney:\n\n(a) means a primary malignant neoplasm arising from the renal tubular epithelium; and\n\n(b) includes renal medullary carcinoma; and\n\n(c) excludes:\n\n(i) carcinoid tumour;\n\n(ii) Hodgkin's lymphoma;\n\n(iii) malignant neoplasm of the renal pelvis;\n\n(iv) non-Hodgkin lymphoma; and\n\n(v) soft tissue sarcoma.\n\n> Note: Malignant neoplasm of the kidney is also known as adenocarcinoma of the kidney, renal cell carcinoma, renal adenocarcinoma and hypernephroma.\n\n(3) While malignant neoplasm of the kidney attracts ICD‑10‑AM code C64, in applying this Statement of Principles the meaning of malignant neoplasm of the kidney is that given in subsection (2).\n\n(4) For subsection (3), a reference to an ICD-10-AM code is a reference to the code assigned to a particular kind of injury or disease in The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision, Australian Modification (ICD-10-AM), Tenth Edition, effective date of 1 July 2017, copyrighted by the Independent Hospital Pricing Authority, ISBN 978-1-76007-296-4.\n\nDeath from malignant neoplasm of the kidney\n\n(5) For the purposes of this Statement of Principles, malignant neoplasm of the kidney, in relation to a person, includes death from a terminal event or condition that was contributed to by the person's malignant neoplasm of the kidney.\n\n> Note: terminal event is defined in the Schedule 1 - Dictionary.\n\n8 Basis for determining the factors\n\nThe Repatriation Medical Authority is of the view that there is sound medical‑scientific evidence that indicates that malignant neoplasm of the kidney and death from malignant neoplasm of the kidney can be related to relevant service rendered by veterans, members of Peacekeeping Forces, or members of the Forces under the VEA, or members under the MRCA.\n\n> Note: MRCA, relevant service and VEA are defined in the Schedule 1 - Dictionary.\n\n9 Factors that must exist\n\nAt least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of the kidney or death from malignant neoplasm of the kidney with the circumstances of a person's relevant service:\n\n(1) having hypertension for a period of at least two years before the clinical onset of malignant neoplasm of the kidney;\n\n(2) being overweight or obese for at least three years within the 20 years before the clinical onset of malignant neoplasm of the kidney;\n\n> Note: being overweight or obese is defined in the Schedule 1 - Dictionary.\n\n(3) having smoked tobacco products:\n\n(a) in an amount of at least ten pack-years before the clinical onset of malignant neoplasm of the kidney; and\n\n(b) commencing at least five years before the clinical onset of malignant neoplasm of the kidney; and\n\nif smoking has ceased before the clinical onset of malignant neoplasm of the kidney, then that onset occurred within 30 years of cessation;\n\n> Note: one pack-year is defined in the Schedule 1 - Dictionary.\n\n(4) having been exposed to second-hand smoke:\n\n(a) for at least 10,000 hours before the clinical onset of malignant neoplasm of the kidney; and\n\n(b) commencing at least five years before the clinical onset of malignant neoplasm of the kidney; and\n\nif exposure to second-hand smoke has ceased before the clinical onset of malignant neoplasm of the kidney, then that onset occurred within 30 years of cessation;\n\n> Note: having been exposed to second-hand smoke is defined in the Schedule 1 - Dictionary.\n\n(5) inhaling respirable asbestos fibres in an enclosed space, at the time material containing asbestos was being applied, removed, cut, drilled, dislodged or disturbed:\n\n(a) for a cumulative period of at least 1,000 hours before the clinical onset of malignant neoplasm of the kidney; and\n\n(b) where the first inhalation of asbestos fibres commenced at least five years before the clinical onset of malignant neoplasm of the kidney;\n\n> Note: Disturbance of debris or dust contaminated with asbestos fibres already present in an enclosed space may result in exposure to respirable asbestos fibres.\n\n(6) inhaling respirable asbestos fibres in an open environment, at the time material containing asbestos was being applied, removed, cut, drilled, dislodged or disturbed:\n\n(a) for a cumulative period of at least 3,000 hours before the clinical onset of malignant neoplasm of the kidney; and\n\n(b) where the first inhalation of asbestos fibres commenced at least five years before the clinical onset of malignant neoplasm of the kidney;\n\n> Note: Disturbance of debris or dust contaminated with asbestos fibres already present in an open environment may result in exposure to respirable asbestos fibres.\n\n(7) inhaling cadmium fumes:\n\n(a) for a cumulative period of at least 3,000 hours before the clinical onset of malignant neoplasm of the kidney; and\n\n(b) where the first inhalation of fumes occurred at least five years before the clinical onset of malignant neoplasm of the kidney;\n\n> Note: cadmium fumes is defined in the Schedule 1 - Dictionary.\n\n(8) inhaling, ingesting or having cutaneous contact with trichloroethylene:\n\n(a) for a cumulative period of at least 1,000 hours, within a consecutive period of ten years, before the clinical onset of malignant neoplasm of the kidney; and\n\n(b) where the first exposure occurred at least five years before the clinical onset of malignant neoplasm of the kidney;\n\n(9) being exposed to arsenic as specified before the clinical onset of malignant neoplasm of the kidney, where the first exposure to arsenic occurred at least ten years before the clinical onset of malignant neoplasm of the kidney;\n\n> Note: being exposed to arsenic as specified is defined in the Schedule 1 - Dictionary.\n\n(10) having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to the kidney at least five years before the clinical onset of malignant neoplasm of the kidney;\n\n> Note: cumulative equivalent dose is defined in the Schedule 1 - Dictionary.\n\n(11) having chronic kidney disease before the clinical onset of malignant neoplasm of the kidney;\n\n> Note: chronic kidney disease is defined in the Schedule 1 - Dictionary.\n\n(12) having renal stone disease involving the affected kidney at least five years before the clinical onset of malignant neoplasm of the kidney;\n\n(13) having diabetes mellitus for at least five years before the clinical onset of malignant neoplasm of the kidney;\n\n(14) for renal medullary carcinoma only, having sickle cell disorder before the clinical onset of renal medullary carcinoma;\n\n(15) an inability to consume an average of at least 200 grams per day of any combination of fruits and vegetables, for a period of at least five consecutive years within the 20 years before the clinical onset of malignant neoplasm of the kidney;\n\n(16) an inability to undertake any physical activity greater than three METs for at least ten years within the 30 years before the clinical onset of malignant neoplasm of the kidney;\n\n> Note: MET is defined in the Schedule 1 - Dictionary.\n\n(17) undergoing organ or tissue transplantation, excluding corneal transplant, before the clinical onset of malignant neoplasm of the kidney;\n\n> Note: organ or tissue transplantation is defined in the Schedule 1 - Dictionary.\n\n(18) taking a non-topical non-steroidal anti-inflammatory drug, excluding aspirin, on at least 15 days per month for at least ten years before the clinical onset of malignant neoplasm of the kidney;\n\n(19) using manual welding equipment for welding metal:\n\n(a) for a cumulative period of at least 3,000 hours before the clinical onset of malignant neoplasm of the kidney; and\n\n(b) where that use began at least five years before the clinical onset of malignant neoplasm of the kidney;\n\n(20) inability to obtain appropriate clinical management for malignant neoplasm of the kidney.\n\n10 Relationship to service\n\n(1) The existence in a person of any factor referred to in section 9, must be related to the relevant service rendered by the person.\n\n(2) The factor set out in subsection 9(20) applies only to material contribution to, or aggravation of, malignant neoplasm of the kidney where the person's malignant neoplasm of the kidney was suffered or contracted before or during (but did not arise out of) the person's relevant service.\n\n11 Factors referring to an injury or disease covered by another Statement of Principles\n\nIn this Statement of Principles:\n\n(1) if a factor referred to in section 9 applies in relation to a person; and\n\n(2) that factor refers to an injury or disease in respect of which a Statement of Principles has been determined under subsection 196B(2) of the VEA;\n\nthen the factors in that Statement of Principles apply in accordance with the terms of that Statement of Principles as in force from time to time.\n\nSchedule 1 \\- Dictionary\n\nNote: See Section 6\n\n1 Definitions\n\nIn this instrument:\n\nabnormality of kidney structure or function means:\n\n(a) having a glomerular filtration rate of less than 60 mL/min/1.73 m2; or\n\n(b) having kidney damage, as evidenced by renal biopsy, imaging studies, albuminuria, urinary sediment abnormalities or other markers of abnormal renal function; or\n\n(c) having had a kidney transplant.\n\nbeing exposed to arsenic as specified means:\n\n(a) consuming drinking water with an average arsenic concentration of at least 50 micrograms per litre for a cumulative period of at least ten years; or\n\n(b) consuming drinking water resulting in a cumulative total arsenic exposure equivalent to having consumed drinking water containing at least 50 micrograms per litre for at least ten years; or\n\n(c) having clinical evidence of chronic arsenic toxicity.\n\nbeing overweight or obese means:\n\n(a) having a Body Mass Index (BMI) of 25 or greater; or\n\n(b) having a waist circumference of greater than 80 centimetres in women or greater than 94 centimetres in men.\n\n> Note: BMI is also defined in the Schedule 1 - Dictionary.\n\nBMI means W/H2 where:\n\n(a) W is the person's weight in kilograms; and\n\n(b) H is the person's height in metres.\n\ncadmium fumes means combustion products, aerosols, vapours or dust arising through industrial processes or from workplace practices that involve the refining, manufacture or use of cadmium.\n\nchronic kidney disease means an abnormality of kidney structure or function that has been present for at least three months.\n\n> Note: abnormality of kidney structure or function is also defined in the Schedule 1 - Dictionary.\n\ncumulative equivalent dose means the total dose of ionising radiation received by the particular organ or tissue from external exposure, internal exposure or both, apart from normal background radiation exposure in Australia, calculated in accordance with the methodology set out in Guide to calculation of 'cumulative equivalent dose' for the purpose of applying ionising radiation factors contained in Statements of Principles determined under Part XIA of the Veterans' Entitlements Act 1986 (Cth), Australian Radiation Protection and Nuclear Safety Agency, as in force on 2 August 2017.\n\n> Note 1: Examples of circumstances that might lead to exposure to ionising radiation include being present during or subsequent to the testing or use of nuclear weapons, undergoing diagnostic or therapeutic medical procedures involving ionising radiation, and being a member of an aircrew, leading to increased levels of exposure to cosmic radiation.\n\n> Note 2: For the purpose of dose reconstruction, dose is calculated as an average over the mass of a specific tissue or organ. If a tissue is exposed to multiple sources of ionising radiation, the various dose estimates for each type of radiation must be combined.\n\nhaving been exposed to second-hand smoke means having been in an enclosed space and inhaling smoke from burning tobacco products or smoke that has been exhaled by another person who is smoking.\n\nmalignant neoplasm of the kidney—see subsection 7(2).\n\nMET means a unit of measurement of the level of physical exertion. 1 MET = 3.5 ml of oxygen/kg of body weight per minute, or 1.0 kcal/kg of body weight per hour, or resting metabolic rate.\n\nMRCA means the Military Rehabilitation and Compensation Act 2004.\n\none pack-year means the amount of tobacco consumed in smoking 20 cigarettes per day for a period of 1 year, or an equivalent amount of tobacco products.\n\n> Note 1: An equivalent amount of tobacco products is 7,300 grams of smoking tobacco by weight, either in cigarettes, pipe tobacco or cigars, or a combination of same. For pipe tobacco, cigars or combinations of multiple tobacco types, 1 gram of tobacco is considered to be equal to one cigarette.\n\n> Note 2: Pack-years are calculated by dividing the number of cigarettes smoked per day by 20 and multiplying this number by the number of years the person has smoked. For example, smoking 10 cigarettes per day for 10 years is equal to 5 pack-years, and smoking 40 cigarettes per day for 10 years is equal to 20 pack-years.\n\norgan or tissue transplantation means:\n\n(a) the transplantation of all or part of an organ or tissue; or\n\n(b) the transplantation of a substance obtained from an organ or tissue.\n\nrelevant service means:\n\n(a) operational service under the VEA;\n\n(b) peacekeeping service under the VEA;\n\n(c) hazardous service under the VEA;\n\n(d) British nuclear test defence service under the VEA;\n\n(e) warlike service under the MRCA; or\n\n(f) non-warlike service under the MRCA.\n\n> Note: MRCA and VEA are also defined in the Schedule 1 - Dictionary.\n\nterminal event means the proximate or ultimate cause of death and includes the following:\n\n(a) pneumonia;\n\n(b) respiratory failure;\n\n(c) cardiac arrest;\n\n(d) circulatory failure; or\n\n(e) cessation of brain function.\n\nVEA means the Veterans' Entitlements Act 1986.\n\n> Note: Endnotes\n\n> Note: Endnote 1—About the endnotes\n\nThe endnotes provide information about this compilation and the compiled law.\n\nThe following endnotes are included in every compilation:\n\nEndnote 1—About the endnotes\n\nEndnote 2—Abbreviation key\n\nEndnote 3—Legislation history\n\nEndnote 4—Amendment history\n\nAbbreviation key—Endnote 2\n\nThe abbreviation key sets out abbreviations that may be used in the endnotes.\n\nLegislation history and amendment history—Endnotes 3 and 4\n\nAmending laws are annotated in the legislation history and amendment history.\n\nThe legislation history in endnote 3 provides information about each law that has amended (or will amend) the compiled law. The information includes commencement details for amending laws and details of any application, saving or transitional provisions that are not included in this compilation.\n\nThe amendment history in endnote 4 provides information about amendments at the provision (generally section or equivalent) level. It also includes information about any provision of the compiled law that has been repealed in accordance with a provision of the law.\n\nMisdescribed amendments\n\nA misdescribed amendment is an amendment that does not accurately describe the amendment to be made. If, despite the misdescription, the amendment can be given effect as intended, the amendment is incorporated into the compiled law and the abbreviation “(md)” added to the details of the amendment included in the amendment history.\n\nIf a misdescribed amendment cannot be given effect as intended, the abbreviation “(md not incorp)” is added to the details of the amendment included in the amendment history.\n\n> Note: Endnote 2—Abbreviation key\n\n|                                                | o = order(s)                        |\n| ---------------------------------------------- | ----------------------------------- |\n| ad = added or inserted                         | Ord = Ordinance                     |\n| am = amended                                   | orig = original                     |\n| amdt = amendment                               | par = paragraph(s)/subparagraph(s)  |\n| c = clause(s)                                  | /sub‑subparagraph(s)                |\n| C[x] = Compilation No. x                       | pres = present                      |\n| Ch = Chapter(s)                                | prev = previous                     |\n| def = definition(s)                            | (prev…) = previously                |\n| Dict = Dictionary                              | Pt = Part(s)                        |\n| disallowed = disallowed by Parliament          | r = regulation(s)/rule(s)           |\n| Div = Division(s)                              |                                     |\n| exp = expires/expired or ceases/ceased to have | reloc = relocated                   |\n| effect                                         | renum = renumbered                  |\n| F = Federal Register of Legislation            | rep = repealed                      |\n| gaz = gazette                                  | rs = repealed and substituted       |\n| LA = Legislation Act 2003                      | s = section(s)/subsection(s)        |\n| LIA = Legislative Instruments Act 2003         | Sch = Schedule(s)                   |\n| (md) = misdescribed amendment can be given     | Sdiv = Subdivision(s)               |\n| effect                                         | SLI = Select Legislative Instrument |\n| (md not incorp) = misdescribed amendment       | SR = Statutory Rules                |\n| cannot be given effect                         | Sub‑Ch = Sub‑Chapter(s)             |\n| mod = modified/modification                    | SubPt = Subpart(s)                  |\n| No. = Number(s)                                | underlining = whole or part not     |\n|                                                | commenced or to be commenced        |\n\n> Note: Endnote 3—Legislation history\n\n| Name                                                                                                                          | Registration              | Commencement      | Application, saving and transitional provisions |\n| ----------------------------------------------------------------------------------------------------------------------------- | ------------------------- | ----------------- | ----------------------------------------------- |\n| Statement of Principles concerning malignant neoplasm of the kidney (Reasonable Hypothesis) (No. 41 of 2021)                  | 29 March 2021F2021L00358  | 27 April 2021     |                                                 |\n| Veterans' Entitlements (Statements of Principles—definition of \"one pack-year\") Amendment Determination 2022 (No. 94 of 2022) | 26 August 2022F2022L01128 | 19 September 2022 |                                                 |\n\n> Note: Endnote 4—Amendment history\n\n| Provision affected                             | How affected      |\n| ---------------------------------------------- | ----------------- |\n| Section 2……………….                               | rep LA s 48D      |\n| Section 4……………….                               | rep LA s 48C      |\n| Subsection 9(3) note.....                      | rs No. 94 of 2022 |\n| Schedule 1 – Dictionary – one pack-year...…….. | rs No. 94 of 2022 |","sortOrder":0}],"analysis":{"kimi_summary":{"content_quality":"ok","complexity_score":6,"scope_assessment":{"changed":false,"description":"This is a standard Statement of Principles instrument made under the Veterans' Entitlements Act 1986. It follows the established template and scope for determining service-related disease connections. The legislation remains focused on its original purpose: establishing medical criteria for linking kidney cancer to military service. The 2022 amendment was minor, updating only the definition of 'one pack-year' for consistency across all Statements of Principles, without expanding the substantive scope."},"complexity_factors":["20 distinct factors with specific quantitative thresholds (e.g., 'at least 10 pack-years', 'at least 1,000 hours', 'at least 50 micrograms per litre')","Nested temporal requirements within factors (e.g., factor 9(3) requires smoking amount, commencement timing, AND cessation timing if applicable)","14 defined terms in Schedule 1 Dictionary, several with mathematical formulas (BMI calculation) or technical medical definitions","Cross-referencing between factors and definitions (e.g., 'being overweight or obese' defined separately with alternative measurement criteria)","Specific exclusions in the disease definition (subsection 7(2)) that require medical knowledge to distinguish from inclusions","Reference to external technical standards (ICD-10-AM Tenth Edition) and external methodology documents (ARPANSA guide for radiation dose calculation)","Conditional logic for different exposure environments (enclosed vs. open space asbestos exposure with different hour thresholds)","Interaction provision (section 11) requiring reference to other Statements of Principles for interconnected conditions"],"plain_english_summary":"This instrument sets the medical rules for deciding whether Australian Defence Force members, veterans and their families can obtain compensation for kidney cancer under veterans’ legislation. It defines qualifying kidney cancers and lists 20 medical or exposure-related factors (e.g., smoking, asbestos/cadmium, obesity, hypertension, certain meds, radiation) that, if shown, create a “reasonable hypothesis” the cancer was service-related.\n\nIt matters because it is the gatekeeper for claims: showing one listed factor during eligible service can support compensation without proof beyond doubt."},"flash_summary":{"complexity_score":5,"scope_assessment":{"changed":true,"description":"The compilation records a post‑enactment amendment (No. 94 of 2022) that revised the definition of “one pack‑year.” That amendment alters how smoking exposure is quantified for factor 9(3), and so can change which claimants meet the smoking‑related threshold without otherwise altering the list of covered conditions or exposures."},"complexity_factors":["Many quantitative medical and exposure thresholds (e.g. pack‑years, cumulative hours, sievert dose) that require precise measurement or reconstruction.","Multiple temporal windows and latency requirements (e.g. exposures must begin at least 5 or 10 years before clinical onset; cessation windows like 30 years for smoking).","Numerous cross‑references to defined terms in the Dictionary (BMI, MET, chronic kidney disease, cumulative equivalent dose, etc.), increasing interpretive work.","Technical radiological dose reconstruction methodology is required for ionising radiation factors (references external Guide).","Overlap with other Statements of Principles: factors that refer to other injuries/diseases require application of those separate SOPs.","Clinical diagnostic specificity (primary renal tubular epithelium origin; exclusions such as renal pelvis tumours or lymphomas) necessitates detailed pathology evidence.","Mixed exposure pathways (inhalation, ingestion, cutaneous contact) and different thresholds by environment (enclosed vs open asbestos exposure) add complexity to occupational histories.","Administrative determination of whether a factor was “related to the relevant service” introduces legal/medical judgment and potential discretionary assessment.","Some factors hinge on long‑term lifestyle measures (BMI, diet, physical activity) that depend on historical records or retrospective estimation.","Amendments to measurement definitions (e.g. one pack‑year) change how exposure is quantified for claims, requiring updates to assessments."],"plain_english_summary":"Mechanically, this Statement lists specific medical conditions, exposures, dose thresholds and time windows that will, if shown to exist and be linked to a person’s relevant service, raise a “reasonable hypothesis” that kidney cancer (or death from it) is related to that service. It applies to claims under the Veterans' Entitlements Act and the Military Rehabilitation and Compensation Act and affects veterans/members seeking entitlements. If claimants can show the listed factor(s) and a service link, claims administrators may accept causation; claimants must supply medical and exposure history to meet those thresholds."},"flash_summary_failed":{"failed":true,"reason":"Unauthenticated. Configure AI_GATEWAY_API_KEY or use a provider module. Learn more: https://ai-sdk.dev/unauthenticated-ai-gateway","source":"analysis-cron"}},"importantCases":[],"_links":{"self":"/api/acts/statement-of-principles-concerning-malignant-neoplasm-of-the-kidney-reasonable-hypothesis-no-41-of-2","history":"/api/acts/statement-of-principles-concerning-malignant-neoplasm-of-the-kidney-reasonable-hypothesis-no-41-of-2/history","analysis":"/api/acts/statement-of-principles-concerning-malignant-neoplasm-of-the-kidney-reasonable-hypothesis-no-41-of-2/analysis","conflicts":"/api/acts/statement-of-principles-concerning-malignant-neoplasm-of-the-kidney-reasonable-hypothesis-no-41-of-2/conflicts","importantCases":"/api/acts/statement-of-principles-concerning-malignant-neoplasm-of-the-kidney-reasonable-hypothesis-no-41-of-2/important-cases","documents":"/api/acts/statement-of-principles-concerning-malignant-neoplasm-of-the-kidney-reasonable-hypothesis-no-41-of-2/documents"}}